Structured evidence table for Black Cumin Seed Sleep Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Black Cumin Seed Sleep Randomized Trial | Non-pharmacological complementary and alternative medicine (CAM) approaches are widely used in KOA care, but randomized controlled trial (RCT) evidence is distributed across diverse intervention types, settings, comparators, and outcome measures. | 2 | Kang Y (2026) | Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials. |
| Black Cumin Seed Sleep Randomized Trial | Methods Following the Arksey and O'Malley scoping review framework and the PRISMA-ScR reporting guideline, we searched PubMed, Web of Science, Embase, and the Cochrane Library for RCTs published from 1 January 2016 to 10 January 2026. | 2 | Kang Y (2026) | Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials. |
| Black Cumin Seed Sleep Randomized Trial | Evidence was summarized descriptively and narratively; no pooled treatment-effect estimates were calculated. | 2 | Kang Y (2026) | Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials. |
| Black Cumin Seed Sleep Randomized Trial | Background Knee osteoarthritis (KOA) is a prevalent chronic degenerative joint disorder and a major contributor to pain, disability, and impaired quality of life. | 2 | Kang Y (2026) | Non-Pharmacological Complementary and Alternative Therapies for Knee Osteoarthritis: A Scoping Review of Randomized Controlled Trials. |
| Black Cumin Seed Sleep Randomized Trial | These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Black Cumin Seed Sleep Randomized Trial | Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia [,]. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Black Cumin Seed Sleep Randomized Trial | Studies have demonstrated a direct correlation between inadequate sleep and an increased risk of developing metabolic diseases, such as diabetes, obesity, hypertension, cardiovascular disease, and depression [,,]. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Black Cumin Seed Sleep Randomized Trial | 1 2 2 3 4 3 5 6 6 4 6 The etymology of the term “insomnia” derives from Latin, combining “in” meaning “not” and “somnus,” meaning “sleep” []. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
Source documents